Preparation of biowaste derived multifunctional akermanite/larnite composite biomaterial for orthopaedic applications

Document Type

Article

Publication Date

6-1-2026

Abstract

Bioactive silicates have garnered significant attention for biomedical applications owing to their vital role in bone tissue regeneration. However, silicate ceramics such as akermanite often exhibit limited interfacial bonding with host tissues due to a low rate of apatite deposition in physiological environments. The present study aimed to overcome these limitations and promote akermanite as an improved bone substitute. In this work, akermanite and larnite (AK-LA) derived from biowaste were combined into a ceramic/ceramic composite using the solid-state method to enhance the hydroxyapatite (HAp) nucleation ability of akermanite. The XRD confirmed the phase purity, and FT-IR analysis identified the functional groups. Manual grinding was used to prepare composites of biowaste-derived akermanite and larnite in ratios of 80:20, 70:30, and 60:40, respectively. Atomic Absorption Atomic Absorption Spectroscopy (AAS) verified that the biowaste precursors were free from toxic heavy metals; only trace levels of non-toxic metals were detected, which were well within the permissible limits defined by ISO standards. Dynamic Light Scattering (DLS) analysis revealed average particle sizes of 3691 nm (AK-LA1), 2816 nm (AK-LA2), and 2547 nm (AK-LA3), indicating low-micron-sized particles. The decrease in particle size with increasing akermanite content suggests composition-dependent grain growth, where smaller particles provide greater surface area and facilitate ion exchange and HAp formation during simulated body fluid (SBF) immersion. Bioactivity studies exhibited excellent HAp deposition within nine days of SBF immersion. Among the composites, AK-LA3 (60:40) showed improved bioactivity, controlled degradation, and superior mechanical strength of 202 MPa. The composite demonstrated pronounced antibacterial activity against E. coli , P. aeruginosa , S. epidermidis , and S. aureus , along with antifungal efficacy against Aspergillus niger , highlighting its ability to prevent implant-related infections. The biocompatibility assessment revealed that AK-LA2 exhibited the highest hAD-MSCs viability (78 %) due to its optimal balance of bioactive ions and surface properties. These results emphasise that the akermanite-to-larnite ratio critically influences both the mechanical and biological behaviour, with AK-LA2 displaying superior biocompatibility, and overall potential for bone tissue engineering and orthopaedic applications.

Keywords

Biocompatibility, Biowaste akermanite/larnite, Composite, Hemolysis, Mechanical strength

Publication Title

Journal of the European Ceramic Society

ISSN

0955-2219

DOI

10.1016/j.jeurceramsoc.2025.118085

Volume

46

Issue

6

Share

COinS